Navigation Links
MAP Pharmaceuticals Announces Phase 3 Study of Unit Dose Budesonide in Children With Asthma Did Not Meet Primary Endpoints
Date:2/23/2009

t AstraZeneca

AstraZeneca is a major international healthcare business engaged in the research, development, manufacturing and marketing of meaningful prescription medicines and supplier for healthcare services. AstraZeneca is one of the world's leading pharmaceutical companies with healthcare sales of US$ 31.6 billion and is a leader in gastrointestinal, cardiovascular, neuroscience, respiratory, oncology and infectious disease medicines. For more information about AstraZeneca, please visit: http://www.astrazeneca.com

Forward-Looking Statements

In addition to statements of historical facts or statements of current conditions, this press release contains forward-looking statements, including with respect to the clinical development of UDB and the collaboration between MAP Pharmaceuticals and AstraZeneca. Actual results may differ materially from current expectations based on risks and uncertainties affecting the company's business, including, without limitation, the conduct and timing of clinical trials, risks and uncertainties relating to the failure to achieve favorable outcomes or to have UDB approved for commercial use by the U.S. Food and Drug Administration; and the risk that AstraZeneca may not continue its collaboration with MAP Pharmaceuticals. The reader is cautioned not to unduly rely on the forward-looking statements contained in this press release. MAP Pharmaceuticals expressly disclaims any intent or obligation to update these forward-looking statements, except as required by law. Additional information on potential factors that could affect MAP Pharmaceuticals' results and other risks and uncertainties are detailed in its Quarterly Report on Form 10-Q, filed with the SEC on November 13, 2008, and available at http://edgar.sec.gov.


'/>"/>
SOURCE MAP Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. AstraZenecas Partner, MAP Pharmaceuticals, Announces Phase 3 Study of Unit Dose Budesonide in Children with Asthma Did Not Meet Primary Endpoints
2. Shareholder Class Action Filed Against Rigel Pharmaceuticals, Inc. by the Law Firm of Barroway Topaz Kessler Meltzer & Check, LLP
3. Access Licenses ProLindac(TM) and MuGard(TM) to JCOM Ltd, an Affiliate of DONG-A Pharmaceuticals in Korea
4. Inspiration Biopharmaceuticals, Inc. Initiates Phase 1 Clinical Trial of IB1001 for the Treatment of Hemophilia B
5. Endo Pharmaceuticals Announces Research Collaborations to Develop Novel Pain Treatments and Discover Potential Cancer Treatments
6. Sequoia Pharmaceuticals Presents Proof of Clinical Concept of SPI-452, a Novel Pharmacokinetic Enhancer
7. Indevus Pharmaceuticals Announces PRO 2000 Found to Show Promise in Large HIV Prevention Study
8. Idenix Pharmaceuticals and GlaxoSmithKline Sign Worldwide License Agreement for IDX899, a Novel NNRTI for the Treatment of HIV
9. Raptor Pharmaceuticals Announces Completion of Patient Enrollment in Phase 2a Clinical Trial in Non-Alcoholic Steatohepatitis (NASH)
10. Oramed Pharmaceuticals Completes Proof of Concept Study of Insulin Suppository
11. Alseres Pharmaceuticals Completes Enrollment in First Stage of the Altropane(R) POET-2 Phase III Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... 23, 2014 The Board of Directors of ... provider of clinical trial imaging solutions, announced today that ... president and chief executive officer, effective immediately.  Mr. Converse ... and has held the positions of interim president and ... Dr. Charles E. Phelps , Ph.D., chairman of ...
(Date:7/23/2014)... July 23, 2014 Research and Markets ... (ECG) Market by Product, End-user & by Lead Type ... offering. http://photos.prnewswire.com/prnh/20130307/600769 ... into three major segments, namely, holter monitor, resting, and ... valued at $3,683 million in 2013 and is poised ...
(Date:7/23/2014)... July 23, 2014 On Tuesday, July ... filed suit in the 116 th Judicial ... , against RegenLab USA, LLC ("Defendant") ... Business Relationships through false and misleading actions, ... Business Disparagement through libel, disparagement, defamation, misrepresentation, ...
Breaking Medicine Technology:Eric T. Converse Named President And Chief Executive Officer Of VirtualScopics, Inc. 2Eric T. Converse Named President And Chief Executive Officer Of VirtualScopics, Inc. 3Eric T. Converse Named President And Chief Executive Officer Of VirtualScopics, Inc. 4Global Diagnostic Electrocardiograph (Resting, Stress, Holter Monitor) (ECG) Market - Forecast to 2020 2Global Diagnostic Electrocardiograph (Resting, Stress, Holter Monitor) (ECG) Market - Forecast to 2020 3
(Date:7/23/2014)... WEDNESDAY, July 23, 2014 (HealthDay News) -- Painful or ... skin cancer, researchers report. "Patients sometimes have multiple ... itchy or painful should raise high concerns for non-melanoma ... dermatology at Temple University School of Medicine, said in ... looked at the medical records of 268 patients who ...
(Date:7/23/2014)... Officials from China,s Northwest Agricultural and Forestry University in ... signed a memorandum of agreement that lays the groundwork ... Safety in China. , The signing ceremony was held ... between high-level officials of the U.S. Department of Agriculture ... agreement is a landmark event for UC Davis and ...
(Date:7/23/2014)... The American Telemedicine Association (ATA) ... annual meeting and tradeshow focused exclusively on telemedicine, ... over 5,000 attendees and more than 250 cutting-edge ... 2015, in Los Angeles. , ATA’s annual meeting ... from researchers, clinicians, hospital and university administrators, program ...
(Date:7/23/2014)... 23, 2014 Bodybuilding.com, the Internet’s most-visited ... of nutritional supplements, has officially opened the polls for ... , the fastest growing sports nutrition company, is up ... of the Year, Best Tasting Protein of the Year- ... of the year - Whey-HD™, Pre-workout Supplement of the ...
(Date:7/23/2014)... The voice on the recording was low and ... news he was infected with the human immunodeficiency virus (HIV) that ... next thing you know I was on the floor flat on ... was hopeful when the recording ended less than 10 minutes later. ... . because it is just God setting you up for ...
Breaking Medicine News(10 mins):Health News:Painful, Itchy Patches Could Be Sign of Skin Cancer 2Health News:Global food safety research agreement signed by China and UC Davis 2Health News:Global food safety research agreement signed by China and UC Davis 3Health News:ATA Seeks Speakers to Present at the World’s Largest Telemedicine, mHealth and Telehealth Conference 2Health News:Vote Now; BPI SPORTS is Nominated for Eight 2014 Bodybuilding.com Supplement Awards 2Health News:Vote Now; BPI SPORTS is Nominated for Eight 2014 Bodybuilding.com Supplement Awards 3Health News:HIV clinic-based audio project emphasizes the power of patient voices 2Health News:HIV clinic-based audio project emphasizes the power of patient voices 3
... Trust for America,s Health (TFAH) ... today entitled Health Care vs. Sick Care. , ... chance to transform our health care system from a sick ... Jeff Levi, PhD, Executive Director of TFAH. "The evidence is ...
... Oct. 28 The cutting-edge of assistive technology--including ... showcased at the Assistive Technology Pavilion at Abilities ... 6-8, 2009 at the Cobb Galleria Convention Center. ... caregivers and healthcare professionals are expected to attend ...
... Inc. (TSX: NRI), a Canadian drug development company focused on ... to and through the skin using its topical and transdermal ... its immune modulating drug candidate, WF10, today announced its financial ... , , Reent Corporate Developments:, ...
... ... digital radiology laboratory, Spencer Peller of 123Chiropractors.com presents the donation check to Life West ... ... November 3, 2009 -- 123Chiropractors.com, http://www.123chiropractors.com , the world,s largest portal relating to ...
... TORONTO, Oct. 28 /PRNewswire/ - LPBP Inc. (the ... 2009 press release related to the per share ... The per share dividend on the Class B ... on the Class A Common shares of $0.0099 ...
... to examine how physicians care for patients from diverse ... Oct. 28 Connecticut physicians believe they could be ... and ethnic backgrounds if they had training that was ... released today by the Connecticut State Medical Society. ...
Cached Medicine News:Health News:New Health Care vs. Sick Care Ad Campaign Launched by Trust for America's Health and Partnership for Prevention 2Health News:New Health Care vs. Sick Care Ad Campaign Launched by Trust for America's Health and Partnership for Prevention 3Health News:Experience the Future of Assistive Technology at Abilities Expo on November 6-8, 2009 2Health News:Nuvo announces 2009 third quarter financial results 2Health News:Nuvo announces 2009 third quarter financial results 3Health News:Nuvo announces 2009 third quarter financial results 4Health News:Nuvo announces 2009 third quarter financial results 5Health News:Nuvo announces 2009 third quarter financial results 6Health News:Nuvo announces 2009 third quarter financial results 7Health News:Nuvo announces 2009 third quarter financial results 8Health News:Nuvo announces 2009 third quarter financial results 9Health News:Nuvo announces 2009 third quarter financial results 10Health News:Nuvo announces 2009 third quarter financial results 11Health News:Nuvo announces 2009 third quarter financial results 12Health News:World's Largest Resource for and about Chiropractors, 123Chiropractors.com, Donates $15,000 to Life Chiropractic College West 2Health News:World's Largest Resource for and about Chiropractors, 123Chiropractors.com, Donates $15,000 to Life Chiropractic College West 3Health News:CSMS Issues Results of Health Disparities Survey 2
The Snap-In Snap-Out-II Tip Inserts offer a large variety of configurations....
The Optima III 45 cm line of laparoscopic hand instruments is ideal for operative laparoscopic/endoscopic procedures or when a longer instrument is needed....
The ACMI™ line of laparoscopic hand instruments is designed to provide a wide selection of popular surgical devices to meet procedural needs....
Insulated, angled, spoon-shaped design cups the gallbladder, permits clear visualization, and allows easy dissection and control of bleeders....
Medicine Products: